Augmentation of Human Influenza A Virus-Specific Cytotoxic T Lymphocyte Memory by Influenza Vaccine and Adjuvanted Carriers (ISCOMS)

This publication has 18 references indexed in Scilit:

• Memory Cytotoxic T Lymphocyte Responses in Human Immunodeficiency Virus Type 1 (HIV-1)-Negative Volunteers Immunized with a Recombinant Canarypox Expressing gp160 of HIV-1 and Boosted with a Recombinant gp160
  The Journal of Infectious Diseases, 1996
• Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env Gene
  The Journal of Infectious Diseases, 1995
• Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.
  The Journal of Experimental Medicine, 1991
• Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
  Nature, 1990
• Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes.
  The Journal of Experimental Medicine, 1989
• Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
  The Journal of Experimental Medicine, 1988
• In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.
  The Journal of Experimental Medicine, 1984
• Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.
  The Journal of Experimental Medicine, 1981
• Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses
  Nature, 1977
• Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.
  The Journal of Experimental Medicine, 1977